Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C Spies

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2015
A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast CancerCynthia X Ma, Jingqin Luo, Michael Naughton, et al.
JCO Clinical Cancer Informatics|October 17, 2019
Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion ProbesErica K Barnell, Adam Waalkes, Matt C Mosior, et al.
Communications Biology|July 3, 2023
Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survivalEmilee N Kotnik, Mary M Mullen, Nicholas C Spies, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 6, 2018
Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samplesErica K Barnell, Peter Ronning, Katie M Campbell, et al.
Nature Methods|October 15, 2013
DGIdb: mining the druggable genomeMalachi Griffith, Obi L Griffith, Adam C Coffman, et al.
Genome Medicine|November 30, 2019
Standard operating procedure for curation and clinical interpretation of variants in cancerArpad M Danos, Kilannin Krysiak, Erica K Barnell, et al.
Blood Advances|October 17, 2022
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myelomaErica K Barnell, Zachary L Skidmore, Kenneth F Newcomer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2017
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast CancerCynthia X Ma, Feng Gao, Jingqin Luo, et al.
Nature Communications|September 19, 2018
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancerAlex H Wagner, Siddhartha Devarakonda, Zachary L Skidmore, et al.
Nature Communications|September 6, 2018
The prognostic effects of somatic mutations in ER-positive breast cancerObi L Griffith, Nicholas C Spies, Meenakshi Anurag, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2015
A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast CancerCynthia X Ma, Jingqin Luo, Michael Naughton, et al.
JCO Clinical Cancer Informatics|October 17, 2019
Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion ProbesErica K Barnell, Adam Waalkes, Matt C Mosior, et al.
Communications Biology|July 3, 2023
Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survivalEmilee N Kotnik, Mary M Mullen, Nicholas C Spies, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 6, 2018
Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samplesErica K Barnell, Peter Ronning, Katie M Campbell, et al.
Nature Methods|October 15, 2013
DGIdb: mining the druggable genomeMalachi Griffith, Obi L Griffith, Adam C Coffman, et al.
Genome Medicine|November 30, 2019
Standard operating procedure for curation and clinical interpretation of variants in cancerArpad M Danos, Kilannin Krysiak, Erica K Barnell, et al.
Blood Advances|October 17, 2022
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myelomaErica K Barnell, Zachary L Skidmore, Kenneth F Newcomer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2017
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast CancerCynthia X Ma, Feng Gao, Jingqin Luo, et al.
Nature Communications|September 19, 2018
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancerAlex H Wagner, Siddhartha Devarakonda, Zachary L Skidmore, et al.
Nature Communications|September 6, 2018
The prognostic effects of somatic mutations in ER-positive breast cancerObi L Griffith, Nicholas C Spies, Meenakshi Anurag, et al.
Pageof 5